Agile Therapeutics, Inc. (NASDAQ: AGRX) Starts Presentation at NobleCon13
Agile Therapeutics (NASDAQ: AGRX) is a specialty pharmaceutical company that focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate, Twirla, is a once-weekly contraceptive patch currently in phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. For more information, visit…







